The nation of Zimbabwe has turned down a major US health deal valued at 367 million US dollars (272 million pounds) spanning five years over the United States' demand for confidential data.
This move was revealed following a government memo dated December was leaked, indicating that Head of State Emmerson Mnangagwa felt the agreement was "lopsided".
A government representative later stated that the US was requesting health data for research and profit but was unwilling to guarantee the resulting advantages from future treatments.
"We must now begin the challenging and unfortunate task of winding down our support in Zimbabwe," remarked American envoy to Zimbabwe Pamela Tremont publicly.
Her embassy indicated the US had donated more than $1.9bn as health assistance to Zimbabwe during the past two decades.
A doctors' association in Zimbabwe has called for further talks to secure a agreement acceptable to all parties so the country's critical HIV treatment initiative can continue.
Wider Context
This rejection comes after a comparable situation in Kenya, where a high court suspended a related health funding agreement after legal challenges were raised about the security of citizens' medical information.
After returning to office last year, US President Donald Trump has reduced foreign aid and shut down the key foreign aid agency.
The agency had managed aid for the US government, but Trump claimed its expenditure was "wasteful" and his administration was pursuing direct bilateral deals to enhance transparency and accountability.
As per reports, Sixteen African countries have to date agreed to similar agreements, constituting more than $18.3bn in committed funds.
Specifics of the Declined Deal
The funds for Zimbabwe was intended to funded "HIV/Aids treatment and prevention, tuberculosis, malaria, healthcare for mothers and children, and preparing for epidemics".
"We are confident this partnership could have provided immense advantages for the people of Zimbabwe, especially the 1.2 million men, women and children presently on HIV treatment through American-funded programmes," the Ambassador added.
However, official spokesman Nick Mangwana maintained the proposed deal was "unfair".
"Zimbabwe was being asked to surrender its biological resources and data indefinitely, with no equivalent promise of benefiting from any scientific breakthroughs – like vaccines, diagnostics, or treatments – that might result from that provided information," he stated.
"Put simply, our nation would supply the basic resources for scientific discovery without any certainty that the resulting innovations would be accessible to our people if a future pandemic emerge."
Sovereignty and Global Health
He also said that the American exit from the global health body and its push of bilateral health agreements were upending systems already set up via the international health agency.
Mangwana gave as an example its Pathogen Access and Benefit Sharing system designed to manage potential global health emergencies.
"This mechanism is designed to guarantee that when a country provides its data, the resulting advantages – including medicines and cures – are distributed fairly, not commercialised exclusively by those with the capability to develop them."
The government's concerns regarding the US deal "should not be misconstrued as anti-American sentiment," he added.
"We welcome continued dialogue with our American counterparts on how subsequent co-operation might be designed in a way that respects the sovereignty and interests of each country."
Health Experts Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) stated it acknowledged the government's concerns, but recommended that talks need to persist given that much of the country's Aids initiatives were funded by foreign aid.
"Where technical issues arise, including those relating to information security or agreement terms, these can frequently be resolved through detailed discussion and mutually agreed protections," the group added.
The situation highlights the complex debate between receiving much-needed foreign assistance and safeguarding national sovereignty in an ever more data-driven world.